"In Europe, CCS intends to complete the CE Mark self-certification process for the APAS® Independence and the clinicalvalidation of the MRSA AM in the third Quarter. This self-certification process will then enable sales of the instrument inEurope".
You would think if they can achieve this sales to Labor Wislinghof would be imminent as they have had an instrument for ever, If that doesn't happen you would have to ask why not. AGM would be interesting.
What’s the bottom?, page-2
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.45M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.6¢ | $8.421K | 526.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 281683 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 300000 | 1 |
View Market Depth
| Last trade - 15.55pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.000 ( 5.88 %) |
||||
| Open | High | Low | Volume | ||
| 1.6¢ | 1.6¢ | 1.6¢ | 100000 | ||
| Last updated 12.44pm 17/05/2024 ? | |||||
| LBT (ASX) Chart |